peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Financial documents

Shareholders

Shareholders

Top 10 shareholders as of September 30, 2023.

 NameNumber of sharesOwnership in pct
 Redmile Group, LLC10,626,13120.3%
 Nexttobe AB2,155,3794.1%
 Olausson, Thomas1,917,0003.7%
 Fjärde AP-Fonden (AP 4)1,900,0003.6%
 Försäkrings AB Avanza Pension1,765,5063.4%
 Jeansson, Theodor1,559,7493.0%
 Tredje AP-Fonden (AP 3)1,389,6502.6%
 VOB & T Trading AB 644,81.2%
 BWG Invest SARL6001.1%
 Ålandsbanken Abp (Sweden)552,2491.1%
 Other29,333,49855.9%
 Total52,443,962100.0%

Source: IHS Markit/IPREO compiled and processed data from various sources, including Euroclear, Morningstar, Factset and the Swedish Financial Supervisory Authority (Finansinspektionen).

Hansa Biopharma had approximately 21,000 shareholders as of September 30, 2023.

Classification of ownership as per Dec 31, 2022

Region

57%
21%
22%

Category

59%
27%
9%
5%